Try a new search

Format these results:

Searched for:

in-biosketch:true

person:remzif01

Total Results:

331


Saving the J-pouch in a Pediatric Patient - video vignette [Letter]

Aydinli, H Hande; Aytac, Erman; Remzi, Feza H
Failure of an ileal pouch anal anastomosis (IPAA) requires revisional surgery or a permanent diversion. Salvage of the pouch is a challenging and demanding procedure. Management of pouch failure in children, particularly indications for revisional surgery appear to be sparse and widely debated.
PMID: 29802776
ISSN: 1463-1318
CID: 3136762

The use of alvimopan as prophylaxis against post-operative ileus afer bowel resection in patients with inflammatory bowel disease [Meeting Abstract]

Jang, J; Kwok, B; Grucela, A; Bernstein, M; Remzi, F; Hudesman, D; Chen, J; Chang, S
Background: Postoperative ileus (POI) is a temporary delay of coordinated intestinal peristalsis following major abdominal surgery, leading to signifcant symptoms such as nausea, vomiting, abdominal pain, prolonged hospitalization, nosocomial complications, and physical deconditioning. Te use of opioids for postoperative pain control further exacerbates the problem. Opioids bind to the mu receptors in the intestinal tract, leading to gut hypomotility. Alvimopan, an oral, peripherally acting mu-opioid receptor antagonist, was FDA approved in 2008 for use before and afer bowel resection to help prevent and treat POI. Tere are no dedicated studies of alvimopan in patients with inflammatory bowel disease (IBD). Terefore, we conducted a study to investigate alvimopan's role in IBD patients who underwent either laparoscopic or open bowel resection. METHODS: A retrospective chart review was conducted at a 725-bed acute care teaching hospital in New York City between January 2012 and February 2017. Data collected included age, sex, type of IBD, length of stay, post-operative gastrointestinal symptoms (nausea, vomiting, constipation, abdominal distention, frst flatus, frst bowel movement, PO tolerance), and dose of alvimopan, were collected. Te primary outcome was time to GI recovery. Secondary outcomes were: time to frst flatus, time to frst bowel movement, time to tolerating a liquid diet, time to tolerating solid food, and total length of stay. Descriptive statistics reports were created through a secure web-based application called REDCap (Research Electronic Data Capture), and the data were exported into Stata to run further analyses. Of note, approximately 50% of patients who underwent bowel surgery afer March 2015 were placed on a "colon surgery pathwayTM, which is an order set dedicated to strategies that decrease length of stay and post-operative complications. Key features include early feeding, optimized analgesia regimen to allow patients to ambulate, encouraging use of incentive spirometry, and administration of alvimopan peri-procedurally. RESULTS: Of 247 patients, 121 received alvimopan (49.0%) and 126 (51.0%) did not. Te male to female ratio was 51:49. Te mean age of the control group was 44.4 + 16.3 and that of the alvimopan group was 43.2 + 16.4. Patients who received alvimopan had faster GI recovery, with a hazard ratio (HR) of 2.11 (P<0.001), shorter time to frst flatus (HR 2.02, P<0.001), shorter time to frst bowel movement (HR 1.93, P<0.001), shorter time to tolerating liquid diet (HR 2.48, P<0.001), and shorter time to tolerating solid food (HR 2.00, P<0.001). Afer controlling for type of bowel resected (large vs. small bowel), laparoscopic vs. open, age, and type of IBD (ulcerative colitis vs. Crohn's disease) using linear regression, patients who received alvimopan spent 2.59 fewer days in the hospital compared to the control group (P<0.01). CONCLUSION(S): Te results of this study suggest that alvimopan is effective in accelerating the time to GI recovery. Data analysis of all primary and secondary outcomes revealed that alvimopan had a statistically signifcant beneft during the post-operative period of IBD patients undergoing bowel resection. Length of stay for IBD patients was signifcantly decreased with peri-operative use of alvimopan
EMBASE:621500995
ISSN: 1572-0241
CID: 3113192

30-day readmission after ileal pouch anal anastomosis surgery: A report from ACS-NSQIP database [Meeting Abstract]

Hande, A H; Lynn, P; Aytac, E; Grieco, M; Remzi, F
Background: Ileal pouch anal anastomosis (IPAA) is the preferred surgical option in patients with medically refractory ulcerative colitis (UC) to preserve gastrointestinal continuity. Tis study aimed to describe 30-day readmission rates, as well as predictive factors for it from a national dataset. METHODS: Patients who underwent IPAA surgery for UC between 2012 and 2015 were identifed from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database using current procedural terminology codes. Demographics, perioperative, and operative variables were collected. Patients were grouped according to the presence of 30-day readmission: (+)/(-). RESULTS: Query identifed 1882 patients, mean age was 40.8+/- 13.9 years, mean length of stay was 7.2+/- 5 days and postoperative 30-day morbidity rate was 28% (n=530). Most common complications in the study group were transfusion (7.5%), organ space surgical site infection (SSI) (3.3%), reoperation (3%) and superfcial SSI (2%). Twenty-two percent (n=416) were readmitted within 30 days of surgery. Reasons for readmission were: surgical site infection (n=88), dehydration (n=77), small bowel obstruction/ileus (n=38/18) and abdominal pain (n=28). Mean time for readmission was 14+/- 7 days, 39 patients had second readmission and 4 had a third readmission within 30-days of surgery. Multivariate analysis showed an ASA score of 4 [OR: 14.4 (2.3-89.7), P=0.004] and age<40 [OR: 1.3 (1.08-1.7), P=0.006] were associated with 30-day readmission. Preoperative albumin level of <3.5 was associated with a second readmission [OR:3 (1.1-8.2), P=0.02)]. CONCLUSION(S): IPAA surgery for UC has high morbidity. One ffh of patients were readmitted within 30 days from IPAA surgery for UC and one third of them had a second readmission. Tis study brings the possibility and consideration for national health care initiative in surgical management of patients with UC, undergoing IPAA surgery
EMBASE:621500968
ISSN: 1572-0241
CID: 3113202

Factors Associated with Short-Term Morbidity in Patients Undergoing Colon Resection for Crohn's Disease

Aydinli, H Hande; Aytac, Erman; Remzi, Feza H; Bernstein, Mitchell; Grucela, Alexis L
BACKGROUND:Patients undergoing colon resection for Crohn's disease are at risk of developing postoperative complications. The aim of this study is to identify factors associated with short-term (30-day) morbidity in patients undergoing colon resection for Crohn's disease from a national database. METHODS:Patients who underwent colon resection for Crohn's disease in 2015 were identified from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. The groups were classified based on presence of postoperative 30-day complications. The overall morbidity was calculated by including patients who had at least one postoperative complication. Demographics, preoperative, and operative factors were assessed and compared between the two groups. Further multivariate logistic regression analysis was conducted. RESULTS:A total of 1643 patients met the inclusion criteria [mean age of 41.2 (± 15.5) years, 871 (53%) female]. Sixty percent (n = 993) of the procedures were performed laparoscopically and 128 (12.8%) cases were converted to open. Ninety-five patients (5%) underwent emergent resections. Thirty percent (n = 507) of patients had at least one postoperative complication within 30 days of surgery. Ileus (16%), transfusion (7%), and organ-space surgical site infection (6%) were the most common morbidities. Independent risk factors for postoperative morbidity were male gender (p = 0.01), open surgery (p = 0.002), preoperative severe anemia (p = 0.001), and preoperative weight loss (p = 0.04). CONCLUSION/CONCLUSIONS:Approximately one third of the patients who undergo colon resection for Crohn's disease experience postoperative complications. Preoperative optimization of nutrition and anemia may improve outcomes. Laparoscopic technique appears to be the preferred surgical treatment option for resection when feasible.
PMID: 29663305
ISSN: 1873-4626
CID: 3043022

Evaluating the Current Status of Rectal Cancer Care in the US: Where We Stand at the Start of the Commission on Cancer's National Accreditation Program for Rectal Cancer

Brady, Justin T; Xu, Zhaomin; Scarberry, Kelly B; Saad, Amin; Fleming, Fergal J; Remzi, Feza H; Wexner, Steven D; Winchester, David P; Monson, John R T; Lee, Lawrence; Dietz, David W
BACKGROUND:In an effort to improve the quality of rectal cancer care in the US, the American College of Surgeons Commission on Cancer has developed the National Accreditation Program for Rectal Cancer (NAPRC). We aimed to describe the current status of rectal cancer care before implementation of the NAPRC. STUDY DESIGN/METHODS:The 2011-2014 National Cancer Database was queried for non-metastatic rectal cancer patients who underwent proctectomy. The NAPRC process measures evaluated included clinical staging completion, treatment starting fewer than 60 days from diagnosis, CEA level drawn before treatment, tumor regression grading, and margin assessment. The NAPRC performance measures included negative proximal, distal, and circumferential margins, and ≥12 lymph nodes harvested during resection. RESULTS:There were 39,068 patients identified (mean age 62 years, 61.6% male sex). In >85% of patients, clinical staging was completed, treatment was started within 60 days, and all tumor margins were assessed. Pretreatment CEA level (64.6% complete) was the process measure most often omitted. However, completion of all included process measures occurred in only 28.1% of patients. All pathologic margins were negative in 79.8% of patients and 73.2% of specimens reported ≥12 lymph nodes. Overall, 56.3% of patients achieved all performance measures. Patients treated at high-volume centers (>30 cases/year) had higher odds of meeting all performance measures (odds ratio 1.42; p < 0.001). CONCLUSIONS:Overall, very few patients achieved all of the proposed quality measures for rectal cancer care. It will be important to re-evaluate these data after the implementation of the NAPRC.
PMID: 29580675
ISSN: 1879-1190
CID: 3011342

A Novel Closure Technique for Complex Abdominal Wounds

Aydinli, H Hande; Peirce, Colin; Aytac, Erman; Remzi, Feza H
INTRODUCTION/BACKGROUND:Abdominal wound closure is a challenge in patients undergoing colorectal surgery with a complex history of multiple abdominopelvic operations. Loss of domain of the abdominal fascia because of prior laparotomies precludes the use of simple, everyday abdominal wound closure techniques. Furthermore, ongoing intra-abdominal sepsis, with or without a concurrent entero- or colocutaneous fistula, increases the risk of postoperative morbidity and mortality in this patient population. We propose an abdominal wound closure technique for patients with multiple previous complex operations and subsequent ongoing abdominopelvic sepsis. TECHNIQUE/METHODS:Following completion of the intra-abdominal component of the operation, the abdominal wall fascial edges are identified and mobilized to allow for a smooth skin closure. The skin is brought together with a small amount of subcutaneous tissue in the abdominal wound line and sutured with a 1.0 Prolene stitch by using the vertical mattress technique. For both wound edges, a dental roll is inserted between the entry and exit points of the suture, with the suture material placed above and over the dental roll, and thus the dental roll is incorporated within the stitch when it is tied down. These stitches and dental rolls are placed along the length of the wound. No mesh is utilized, and the technique achieves skin closure with development of a subsequent ventral hernia. RESULTS:Good postoperative short-term and long-term overall outcomes were achieved in 14 patients who underwent complex abdominal wound closure. Two patients required further late operative intervention because of the incarceration of the known ventral hernia (at 34 and 120 months postoperatively). CONCLUSIONS:Complex abdominal wound closure in this setting is safe and feasible to achieve a healthy abdominal wall closure and enable healing by primary intention after colorectal surgery.
PMID: 29521836
ISSN: 1530-0358
CID: 2974952

Accreditation Readiness in US Multidisciplinary Rectal Cancer Care: A Survey of OSTRICH Member Institutions

Lee, Lawrence; Dietz, David W; Fleming, Fergal J; Remzi, Feza H; Wexner, Steven D; Winchester, David; Monson, John R T
PMCID:5933378
PMID: 29238809
ISSN: 2168-6262
CID: 2844142

Mesenteric considerations in reoperative abdominal surgery

Chapter by: Calvin Coffey, J; Remzi, F
in: Mesenteric Principles of Gastrointestinal Surgery: Basic and Applied Science by
pp. 333-342
ISBN: 9781498711234
CID: 3330192

Laparoscopic surgery for complex and recurrent Crohn's disease [Editorial]

Sevim, Yusuf; Akyol, Cihangir; Aytac, Erman; Baca, Bilgi; Bulut, Orhan; Remzi, Feza H
Crohn's disease (CD) is a chronic inflammatory disease of digestive tract. Approximately 70% of patients with CD require surgical intervention within 10 years of their initial diagnosis, despite advanced medical treatment alternatives including biologics, immune suppressive drugs and steroids. Refractory to medical treatment in CD patients is the common indication for surgery. Unfortunately, surgery cannot cure the disease. Minimally invasive treatment modalities can be suitable for CD patients due to the benign nature of the disease especially at the time of index surgery. However, laparoscopic management in fistulizing or recurrent disease is controversial. Intractable fibrotic strictures with obstruction, fistulas with abscess formation and hemorrhage are the surgical indications of recurrent CD, which are also complicating laparoscopic treatments. Nevertheless, laparoscopy can be performed in selected CD patients with safety, and may provide better outcomes compared to open surgery. The common complication after laparoscopic intervention is postoperative ileus seems and this may strongly relate excessive manipulation of the bowel during dissection. But additionally, unsuccessful laparoscopic attempts requiring conversion to open surgery have been a major concern due to presumed risk of worse outcomes. However, recent data show that conversions do not to worsen the outcomes of colorectal surgery in experienced hands. In conclusion, laparoscopic treatment modalities in recurrent CD patients have promising outcomes when it is used selectively.
PMCID:5394720
PMID: 28465780
ISSN: 1948-5190
CID: 3177412

Total abdominal colectomy vs. restorative total proctocolectomy as the initial approach to medically refractory ulcerative colitis

Gu, Jinyu; Stocchi, Luca; Ashburn, Jeanie; Remzi, Feza H
PURPOSE/OBJECTIVE:There is scant data assessing the consequences of staging restorative proctocolectomy for ulcerative colitis. The aim of the study is to compare outcomes of initial vs. staged restorative proctocolectomy. METHODS:Patients completing restorative proctocolectomy, including ileostomy reversal, during 2006-2012 were identified from an IRB-approved database. Demographics, treatment variables, and perioperative outcomes were assessed. RESULTS:Out of 521 patients, 322 (62%) underwent initial total abdominal colectomy before restorative proctectomy. This group was associated with more common preoperative anemia, leukocytosis, hypoalbuminemia, severe colitis, steroids and biologics use, decreased proximal ileostomy rate at the time of completion restorative proctectomy (92.5 vs 97.5%, p = 0.023), shorter hospital stay (6.6 vs 7.8, p < 0.001), and marginally decreased pelvic sepsis rate (6.2 vs 11.1%, p = 0.05) compared with patients having initial restorative proctocolectomy. However, they also required longer combined postoperative hospital stays (17 vs 12 days, p < 0.001) and treatment span (10.4 vs 5.7 months, p < 0.001) to complete all surgical stages and they were associated with increased overall postoperative surgical site infection, hemorrhage, and small bowel obstruction rates. Pouch function and QOL were comparable between the groups, except for increased nightly bowel movements in the initial abdominal colectomy group (2.5 ± 2.2 vs 2.1 ± 1.8, p = 0.012). CONCLUSIONS:Patients undergoing initial total abdominal colectomy require longer treatment time and experience increased overall morbidity, but ultimately experience comparable ileal pouch outcomes when compared to patients undergoing initial restorative proctocolectomy.
PMID: 28534070
ISSN: 1432-1262
CID: 3075682